Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-Seq of NIH-3T3 cells treated with CMA modulators

ABSTRACT: RNA-Seq of NIH-3T3 cells treated with CMA modulators

PROVIDER: PRJNA800076 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RNA-Seq of NIH-3T3 cells treated with CMA modulators

Project description:Transcriptomics of NIH-3T3 cells treated with CMA activators to evaluate gene expression changes

2022-06-06 | GSE194292 | GEO

RNA-Seq of NIH-3T3 cells treated with atypical RARa modulators

Project description:Transcriptomics of NIH-3T3 cells treated with typical or atypical RARa modulators to evaluate genetic changes induced by chemical modification of RARa signalling

2022-06-06 | GSE194291 | GEO

RNA-Seq of NIH-3T3 cells treated with atypical RARa modulators

Project description:RNA-Seq of NIH-3T3 cells treated with atypical RARa modulators

| PRJNA800077 | ENA

dynamic SILAC NIH/3T3 treated with DMSO/CHX

Project description:NIH/3T3 cells were cultured at least 2 weeks in light medium: DMEM for SILAC (Thermo scientific) supplemented with PS, dialyzed FBS (Thermo scientific), (light) L-Lysine-2HCl (0.666 mM), (light) L-Arginine-HCl (0.399 mM)44, and L-Proline (200 mg/L). Before switching from light to heavy medium, cells were treated with 0.05 µg/mL CHX or equivalent dilution of DMSO in 6-well plates. At timepoint 0 h, we replaced light medium with pre-warmed heavy medium: DMEM for SILAC (Thermo scientific) supplemented with PS, dialyzed FBS (Thermo scientific), (heavy) 13C6 15N2 L-Lysine-2HCl (0.666 mM), (heavy) 13C6 15N4 L-Arginine-HCl (0.399 mM), and L-Proline (200 mg/L) for NIH/3T3.

2025-10-07 | PXD061384 | Pride

Gli3 co-IP/MS in SAG-treated NIH/3T3 cells

Project description:Co-IP/MS of Gli3 from NIH/3T3 cells treated with the smoothened agonist SAG fractionated into nuclear and cytoplasmic fractions. 10091, 10092, 10093, 10095, 10096 are nuclear fraction samples, 10094, 10097 are cytoplasmic fraction samples.

2023-12-30 | MSV000093738 | MassIVE

NIH-3T3 cell line response to chemotheraputic agents.

Project description:In this study, we treated NIH-3T3 cells with various chemotherapy drugs and RNA sequencing analysis was carried out.

2025-12-03 | GSE262174 | GEO

NIH 3T3: Ctrl vs Reo

Project description:Transcriptional profiling of NIH 3T3 comparing WT, RIG-I KD with and without reovirus infection

2020-10-07 | GSE127850 | GEO

NIH-3T3 cell line response to proteasome inhibitor

Project description:In this study, we compared the transcriptional profile of NIH-3T3 cells that are either wild-type (WT) or Nrf1 knockout (Nrf1-KO). We treated these cells with carfilzomib for 6 hours or 24 hours and performed RNA-sequencing with these samples.

2020-05-21 | GSE144817 | GEO

NIH 3T3: Ctrl vs Reo

Project description:NIH 3T3: Ctrl vs Reo

| PRJNA525645 | ENA

Immediate Early Response 2 (Ier2) overexpression effect in NIH 3T3 cells

Project description:Analysis of Immediate Early Response 2 (Ier2)-inducible NIH 3T3 cells after Ier2 induction with RheoSwitch ligand RSL-1. Results provide insight into the function of Ier2 in NIH 3T3 mouse embryonal fibroblasts. Immediate early genes, including Ier2, are rapidly induced in quiescent cells by proliferation and migration-inducing stimuli. Microarray gene expression profiling was performed to identify differentially expressed genes following overexpression of Ier2 in NIH 3T3-Ier2 inducible cells after 24 hour induction of Ier2.

2021-10-07 | GSE181200 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data